$APUS News

Apimeds Pharmaceuticals Q1 EPS $(2.26) Down From $(0.50) YoY

Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program

Apimeds Pharmaceuticals US Settles All Resolving Disputes With Inscobee Regarding Apimeds Business Combination With MindWave Innovations

Apimeds Pharmaceuticals Appoints Sungjoon Chae Co-CEO, Effective May 4

Apimeds Pharmaceuticals Q4 EPS $(0.80) Down From $(0.50) YoY

Apimeds Pharmaceuticals And Inscobee's Attempt To Oust Board And Officers Deemed Invalid Under Existing Merger Agreements; Vin Menon Continues To Serve As The Company's CEO; Erick Frim Continues To Serve As The Company's CFO

Apimeds Pharmaceuticals shares are trading lower. The company announced material breach of merger agreement by Inscobee, and prepares filing emergency action in Delaware Court of Chancery.

Apimeds Pharmaceuticals shares are trading lower. The company announced material breach of merger agreement by Inscobee, and prepares filing emergency action in Delaware Court of Chancery.

Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery

Apimeds Pharmaceuticals Announces Inscobee Violates Merger Agreement; Prepares Emergency Action To Be Filed In Delaware Court Of Chancery

Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)

Apimeds Pharmaceuticals And Lōkahi Therapeutics Secure FDA Type C Meeting To Discuss LT-100, Non-Opioid Biologic Candidate Being Developed For Osteoarthritis Treatment

Reported Earlier: Apimeds Pharma Announces Merger With MindWave Innovations; No Financial Terms Disclosed

Apimeds Pharmaceuticals Shares Resume Trade

Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation

Apimeds Pharmaceuticals says "I love my Ducks" with new ai² Futures Lab™ Program collaboration with the University of Oregon’s Lundquist College of Business

Apimeds Expands ai Futures Lab With University Of Oregon Partnership To Advance Biopharma Innovation And Train Next-Generation Healthcare Leaders

Reported Earlier, Apimeds And University Of San Diego Partner To Advance Future Labs Program Developing Next Generation Biopharma Business Talent

Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development

Reported Earlier, Apimeds Highlights FDA Draft Guidance On Non-Opioid Analgesics As Key Milestone For Advancing Late-Stage Apitox Pain Therapy